MedTrace Logo

Aequalis Resurfacing Head Study

NCT02444299 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-04-16

No results posted yet for this study

Summary

Aequalis® Resurfacing Head implant is a range of shoulder arthroplasty device available for the treatment of various shoulder pathologies. It received CE Mark in June 2007.

The aim of this study is to collect immediate medium and long term data on performance and safety of the implant, retrospectively as well as prospectively, from a consecutive series of patients to assess the patients' outcomes and functional status.

Conditions

  • Localized, Primary Osteoarthritis
  • Post-traumatic Arthrosis of Other Joints, Shoulder Region
  • Avascular Necrosis of the Head of Humerus

Interventions

DEVICE

Shoulder hemi-arthroplasty

Sponsors & Collaborators

  • Stryker Trauma and Extremities

    lead INDUSTRY

Principal Investigators

  • Lionel NEYTON, MD · Centre Orthopédique Santy, Lyon, FR

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2021-04-30
Completion
2021-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02444299 on ClinicalTrials.gov